Acetylsalicylic acid Recruiting Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) / Severe Acute Respiratory Syndrome / Infections, Coronavirus Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04466670Hemostasis in COVID-19: an Adaptive Clinical Trial
NCT04324463Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial